Reaction
Head Titubation reporting signals
As of the last recalculation, Head Titubation appears in 1,365 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is ASENAPINE MALEATE (PRR 44.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Asenapine Maleate | 25 | 44.8 | 44.9 |
| Quinapril Hydrochloride | 16 | 31.3 | 31.3 |
| Paliperidone | 30 | 20.0 | 20.1 |
| Primidone | 12 | 18.1 | 18.1 |
| Paroxetine Hydrochloride Hemihydrate | 33 | 15.5 | 15.5 |
| Paroxetine | 33 | 15.1 | 15.2 |
| Haloperidol | 23 | 14.7 | 14.7 |
| Haloperidol Lactate | 23 | 14.4 | 14.4 |
| Aripiprazole Oral | 35 | 13.2 | 13.2 |
| Aripiprazole Orally Disintegrating | 35 | 13.2 | 13.2 |
| Valbenazine | 21 | 12.9 | 12.9 |
| Divalproex Sodium | 36 | 12.1 | 12.1 |
| Quetiapine Fumarate | 22 | 11.5 | 11.5 |
| Brivaracetam | 6 | 10.2 | 10.2 |
| Botulinum Toxin Type A | 8 | 9.9 | 9.9 |
| Cannabidiol | 15 | 9.9 | 9.9 |
| Ozanimod Hydrochloride | 5 | 9.2 | 9.2 |
| Vigabatrin | 8 | 8.4 | 8.4 |
| Brexpiprazole | 9 | 8.3 | 8.3 |
| Rasagiline Mesylate | 6 | 8.3 | 8.3 |
| Rocuronium Bromide | 6 | 7.8 | 7.8 |
| Aripiprazole | 60 | 7.8 | 7.8 |
| Levodopa | 6 | 7.6 | 7.6 |
| Clobazam | 12 | 7.6 | 7.6 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 7.2 | 7.2 |
| Lurasidone Hydrochloride | 9 | 6.6 | 6.6 |
| Diroximel Fumarate | 5 | 6.4 | 6.4 |
| Clozapine | 45 | 5.6 | 5.6 |
| Cenobamate | 3 | 5.5 | 5.5 |
| Cariprazine | 3 | 4.9 | 4.9 |
| Dalfampridine | 20 | 4.3 | 4.3 |
| Natalizumab | 43 | 3.7 | 3.7 |
| Onabotulinumtoxina | 17 | 3.4 | 3.4 |
| Romosozumab-Aqqg | 3 | 3.4 | 3.4 |
| Pimavanserin Tartrate | 6 | 1.7 | 1.7 |